COVID-19: AIIMS administers first dose of COVID-19 candidate vaccine 'Covaxin' to 30-year-old Delhi resident

This is the first phase of human clinical trial after the institute's ethics committee gave its approval for the trail for the indigenously developed COVID-19 vaccine candidate Covaxin.